News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,285 Results
Type
Article (43892)
Company Profile (328)
Press Release (664065)
Section
Business (207702)
Career Advice (2019)
Deals (35925)
Drug Delivery (104)
Drug Development (83831)
Employer Resources (171)
FDA (16612)
Job Trends (15077)
News (352223)
Policy (33203)
Tag
Academia (2662)
Alliances (50631)
Alzheimer's disease (1353)
Approvals (16555)
Artificial intelligence (187)
Bankruptcy (358)
Best Places to Work (11831)
Biotechnology (236)
Breast cancer (223)
Cancer (1667)
Cardiovascular disease (134)
Career advice (1682)
CAR-T (128)
Cell therapy (362)
Clinical research (67186)
Collaboration (644)
Compensation (322)
COVID-19 (2636)
C-suite (147)
Data (1525)
Diabetes (205)
Diagnostics (6341)
Earnings (85982)
Employer resources (148)
Events (113406)
Executive appointments (525)
FDA (17430)
Funding (556)
Gene therapy (255)
GLP-1 (693)
Government (4460)
Healthcare (19249)
Infectious disease (2733)
Inflammatory bowel disease (122)
Interviews (311)
IPO (16651)
Job creations (3691)
Job search strategy (1431)
Layoffs (457)
Legal (7976)
Lung cancer (246)
Manufacturing (232)
Medical device (13482)
Medtech (13487)
Mergers & acquisitions (19571)
Metabolic disorders (557)
Neuroscience (1748)
NextGen: Class of 2025 (6710)
Non-profit (4573)
Northern California (1933)
Obesity (318)
Opinion (205)
Patents (141)
People (57765)
Phase I (20957)
Phase II (29548)
Phase III (22054)
Pipeline (647)
Postmarket research (2720)
Preclinical (8888)
Radiopharmaceuticals (256)
Rare diseases (323)
Real estate (6001)
Regulatory (22424)
Research institute (2418)
Resumes & cover letters (352)
Southern California (1670)
Startups (3701)
United States (17489)
Vaccines (613)
Weight loss (232)
Date
Today (103)
Last 7 days (609)
Last 30 days (2499)
Last 365 days (35879)
2025 (2482)
2024 (36308)
2023 (41053)
2022 (52296)
2021 (56827)
2020 (55102)
2019 (47639)
2018 (35958)
2017 (33035)
2016 (32438)
2015 (38445)
2014 (32164)
2013 (27177)
2012 (29331)
2011 (30045)
2010 (28196)
Location
Africa (741)
Arizona (210)
Asia (38786)
Australia (6420)
California (4453)
Canada (1603)
China (386)
Colorado (200)
Connecticut (216)
Europe (85160)
Florida (638)
Georgia (159)
Illinois (442)
Indiana (252)
Maryland (709)
Massachusetts (3471)
Michigan (188)
Minnesota (323)
New Jersey (1249)
New York (1268)
North Carolina (859)
Northern California (1933)
Ohio (161)
Pennsylvania (1029)
South America (1118)
Southern California (1670)
Texas (653)
Utah (127)
Washington State (444)
708,285 Results for "neuropore therapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
·
20 min read
Gene therapy
5 Cardio Gene Therapies on the Near Horizon
Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic for cardiovascular diseases including congestive heart failure, chronic refractory angina and cardiomyopathy.
January 13, 2025
·
9 min read
·
Tristan Manalac
Press Releases
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
January 6, 2025
·
3 min read
Press Releases
Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial
December 23, 2024
·
6 min read
Pharm Country
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will participate at the Jefferies Global Healthcare Conference being held June 5-6, 2024 at the Marriot Marquis in New York.
June 4, 2024
·
3 min read
Press Releases
Qnovia, Inc. Announces First Patient Dosed in U.S. in Phase 1 study for RespiRx™ Nicotine Inhaler as a prescription smoking cessation therapy
January 7, 2025
·
3 min read
Press Releases
Avirmax Inc. to Present at the ARVO Frontiers in Ocular Gene Therapy Research Conference
November 12, 2024
·
2 min read
Press Releases
Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
January 8, 2025
·
5 min read
Press Releases
BrainChild Bio, Inc. to Clinically Advance BCB-276, an Autologous B7-H3 Targeting CAR T-cell Therapy for Incurable Pediatric Brain Tumors
January 7, 2025
·
5 min read
Biotech Beach
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies.
April 29, 2024
·
7 min read
1 of 70,829
Next
